scispace - formally typeset
B

Beatriz da Costa Aguiar Alves

Researcher at University of São Paulo

Publications -  117
Citations -  549

Beatriz da Costa Aguiar Alves is an academic researcher from University of São Paulo. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 9, co-authored 97 publications receiving 438 citations. Previous affiliations of Beatriz da Costa Aguiar Alves include Federal University of São Paulo.

Papers
More filters
Journal ArticleDOI

Characterization of cell-free circulating DNA in plasma in patients with prostate cancer.

TL;DR: Cell-free circulating DNA levels were measured by a quantitative real-time PCR method with a set of primers targeted to amplify the consensus ALU apoptotic versus necrotic origin and all patients after 6 months demonstrated DNA released at non-apoptotic cell.
Journal ArticleDOI

Use of primers derived from a new sequence of the bovine Y chromosome for sexing Bos taurus and Bos indicus embryos.

TL;DR: A bovine male-specific marker was identified in the laboratory through random amplified polymorphic DNA (RAPD) analysis and primers derived from this sequence used for detecting the 655 bp male sequence in DNA from 173 zebu and 30 taurine embryos, which had been previously sexed using primers for the sequence BC 1.2.
Journal ArticleDOI

Sexing of murine and bovine embryos by developmental arrest induced by high-titer H-Y antisera.

TL;DR: The induction of developmental arrest by high-titer male-specific antisera was an efficient strategy for non-invasive embryo sexing and has considerable commercial potential for sexing bovine embryos.
Journal ArticleDOI

The role of Survivin as a biomarker and potential prognostic factor for breast cancer

TL;DR: The importance of the biomarker survivin (Sur) in relation to BC is evaluated, through the detailing of the role of Sur as a biomarker, the correlation between this protein and the prognosis of BC patients, and a summary of therapeutic strategies that target Sur for the development of new anticancer therapies.
Journal ArticleDOI

Systemic chemotherapy interferes in homocysteine metabolism in breast cancer patients.

TL;DR: This study aimed to evaluate homocysteine and its cofators (folic acid and vitamin B12) concentrations and platelet count at diagnosis of BC, 3 and 6 months after the beginning of chemotherapy treatment and to correlate them with clinical data.